• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dogwood Therapeutics, Inc. - Common Stock (NQ:DWTX)

3.150 -0.410 (-11.52%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 140,796
Open 3.570
Bid (Size) 3.150 (100)
Ask (Size) 3.600 (100)
Prev. Close 3.560
Today's Range 3.010 - 3.780
52wk Range 1.870 - 29.28
Shares Outstanding 1,332,178
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
DWTX Stock Heads For Worst Day In 9 Months As Chemotherapy Pain Drug Interim Study Data Fails To Boost Investor Confidence ↗
December 22, 2025
The company said that Halneuron demonstrated separation from placebo treated patients in terms of pain improvement but did not detail the scale of the said improvement. 
Via Stocktwits
News headline image
Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045
December 02, 2025
Via ACCESS Newswire

Performance

YTD
-25.7%
-25.7%
1 Month
-47.6%
-47.6%
3 Month
-43.8%
-43.8%
6 Month
-36.9%
-36.9%
1 Year
+32.4%
+32.4%

More News

Read More
News headline image
Dogwood Announces Enrollment of First 100 Patients in Ongoing Halneuron(R) Phase 2b Trial, Interim Sample Size Analysis on Track for December 2025
November 11, 2025
Via ACCESS Newswire
News headline image
Dogwood Therapeutics Inc (NASDAQ:DWTX) Reports Q3 2025 Results, Focuses on Key Halneuron® Data ↗
November 06, 2025
Via Chartmill
Topics Earnings
News headline image
Dogwood Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
October 30, 2025
Via ACCESS Newswire
News headline image
Dogwood Therapeutics to Participate at the Maxim Growth Summit 2025
October 14, 2025
Via ACCESS Newswire
News headline image
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit
October 07, 2025
Via ACCESS Newswire
News headline image
Which stocks are moving before the opening bell on Thursday? ↗
October 02, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
October 02, 2025
Via Benzinga
News headline image
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket ↗
October 02, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
September 29, 2025
Via Benzinga
News headline image
Dogwood Therapeutics Stock Soars Pre-Market On Securing License For Cancer-Related Pain Management Drug ↗
September 29, 2025
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
September 29, 2025
Via Benzinga
News headline image
Here are the top movers in Monday's session. ↗
April 21, 2025
Via Chartmill
News headline image
Which stocks have an unusual volume on Monday? ↗
April 21, 2025
Via Chartmill
News headline image
Top movers analysis in the middle of the day on 2025-04-21: top gainers and losers in today's session. ↗
April 21, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
April 21, 2025
Via Benzinga
News headline image
The market is filled with gapping stocks in Monday's session. ↗
April 21, 2025
Via Chartmill
News headline image
Nasdaq Tumbles Over 400 Points; Netflix Posts Upbeat Earnings ↗
April 21, 2025
Via Benzinga
News headline image
Which stocks are moving on Thursday? ↗
April 17, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
April 17, 2025
Via Benzinga
News headline image
Tuesday's after hours session: top gainers and losers ↗
April 15, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
April 15, 2025
Via Benzinga
News headline image
Top stock movements in today's session. ↗
April 15, 2025
Via Chartmill
News headline image
Tuesday's session: top gainers and losers ↗
April 15, 2025
Via Chartmill

Frequently Asked Questions

Is Dogwood Therapeutics, Inc. - Common Stock publicly traded?
Yes, Dogwood Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Dogwood Therapeutics, Inc. - Common Stock trade on?
Dogwood Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Dogwood Therapeutics, Inc. - Common Stock?
The ticker symbol for Dogwood Therapeutics, Inc. - Common Stock is DWTX on the Nasdaq Stock Market
What is the current price of Dogwood Therapeutics, Inc. - Common Stock?
The current price of Dogwood Therapeutics, Inc. - Common Stock is 3.150
When was Dogwood Therapeutics, Inc. - Common Stock last traded?
The last trade of Dogwood Therapeutics, Inc. - Common Stock was at 01/08/26 04:00 PM ET
What is the market capitalization of Dogwood Therapeutics, Inc. - Common Stock?
The market capitalization of Dogwood Therapeutics, Inc. - Common Stock is 4.20M
How many shares of Dogwood Therapeutics, Inc. - Common Stock are outstanding?
Dogwood Therapeutics, Inc. - Common Stock has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap